Google Play mobile download button
Apple IOS mobile download button
Google Play mobile download button
Apple IOS mobile download button
HomeBreaking NewsCancer vaccine trials to begin in Britain this year

Cancer vaccine trials to begin in Britain this year

'Quick read' news summary

Cancer vaccine trials will start in the UK this year after the Government signed a deal with BioNTech, the company that created the mRNA technology behind the Pfizer Covid jab.

The agreement will enable BioNTech to conduct cutting-edge clinical trials, with British patients set to be enrolled as soon as autumn. The so-called cancer vaccines are not preventative but are therapeutic tools designed to fight established disease and advanced tumours.

BioNTech created the world’s first authorised mRNA vaccine for Covid in 2020, which works by injecting a person with a small piece of genetic code to create a specific immune response.

It was found to be safe and effective at protecting against severe disease from Covid, and updated omicron-specific jabs are being rolled out to the over-50s.

Britain was the first country to give people the BioNTech vaccine, and the company has now invested an undisclosed amount of money to conduct innovative mRNA vaccine research in the UK.

It is understood a lab of around 70 scientists will be created in Cambridge to spearhead the research, while the firm will also set up a London-based office as its UK headquarters.

Patients will be recruited by the company for the trials via the Cancer Vaccine Launch Pad, which is being created by the NHS and Genomics England and will help researchers find ideal candidates for various drugs. Other companies will also be able to use the tool to match up patients with suitable trials.

Multiple forms of cancer, including breast, lung and pancreatic, will be targeted by BioNTech’s vaccine technology, as well as Covid, malaria and TB.

It is hoped that the technology and partnership will be found to be safe and effective, embedded into standard care and that

Cancer vaccine trials will start in the UK this year after the Government signed a deal with BioNTech, the company that created the mRNA technology behind the Pfizer Covid jab. The so-called cancer vaccines are not preventative but are therapeutic tools designed to fight established disease and advanced tumours. Britain was the first country to give people the BioNTech vaccine, and the company has now invested an undisclosed amount of money to conduct innovative mRNA vaccine research in the UK.

Read different perspectives